APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Carboplatin Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Carboplatin Injection Industry Growth and Trends Forecast to 2032

Report ID 173974990120 December 2025101 pages

Choose your research edition.

Industry ResearchCarboplatin Injection Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Carboplatin Injection Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Carboplatin Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Carboplatin Injection Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Carboplatin Injection Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Carboplatin Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Carboplatin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Carboplatin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Carboplatin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Carboplatin Injection include Hisun, Yunnan Phytopharmaceutical, Yangzijiang Group, Teva, Shanghai Acebright Pharmaceuticals, Shandong Ruiying, Qilu Pharmaceutical, Mylan and Jiangsu Lianhuan Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Carboplatin Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Carboplatin Injection market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Carboplatin Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Carboplatin Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Carboplatin Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Carboplatin Injection Market by Company

Hisun

Yunnan Phytopharmaceutical

Yangzijiang Group

Teva

Shanghai Acebright Pharmaceuticals

Shandong Ruiying

Qilu Pharmaceutical

Mylan

Jiangsu Lianhuan Pharmaceutical

Fresenius Kabi

Cisen Pharmaceutical

Taj Pharmaceuticals

Hospira(Pfizer)

Bristol-Myers Squibb SA

Carboplatin Injection Segment by Type

10ml:50mg

10ml:100mg

Other

Carboplatin Injection Segment by Application

SCLC

Breast Cancer

Ovarian Cancer

Other

Carboplatin Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Carboplatin Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Carboplatin Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Carboplatin Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Carboplatin Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Carboplatin Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 10ml:50mg Table 2. Major Company of 10ml:100mg Table 3. Major Company of Other Table 4. Global Carboplatin Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Carboplatin Injection Sales by Type (2021-2026) & (K Units) Table 6. Global Carboplatin Injection Sales Market Share in Volume by Type (2021-2026) Table 7. Global Carboplatin Injection Sales by Type (2021-2026) & (US$ Million) Table 8. Global Carboplatin Injection Sales Market Share in Value by Type (2021-2026) Table 9. Global Carboplatin Injection Price by Type (2021-2026) & (US$/Unit) Table 10. Global Carboplatin Injection Sales by Type (2027-2032) & (K Units) Table 11. Global Carboplatin Injection Sales Market Share in Volume by Type (2027-2032) Table 12. Global Carboplatin Injection Sales by Type (2027-2032) & (US$ Million) Table 13. Global Carboplatin Injection Sales Market Share in Value by Type (2027-2032) Table 14. Global Carboplatin Injection Price by Type (2027-2032) & (US$/Unit) Table 15. North America Carboplatin Injection Sales by Type (2021-2026) & (K Units) Table 16. North America Carboplatin Injection Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Carboplatin Injection Sales by Type (2021-2026) & (K Units) Table 18. Europe Carboplatin Injection Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Carboplatin Injection Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Carboplatin Injection Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Carboplatin Injection Sales by Type (2021-2026) & (K Units) Table 22. Latin America Carboplatin Injection Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Carboplatin Injection Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Carboplatin Injection Sales by Type (2021-2026) & (US$ Million) Table 25. Carboplatin Injection Industry Trends Table 26. Carboplatin Injection Industry Drivers Table 27. Carboplatin Injection Industry Opportunities and Challenges Table 28. Carboplatin Injection Industry Restraints Table 29. Global Carboplatin Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Carboplatin Injection Revenue Market Share by Company (2021-2026) Table 31. Global Carboplatin Injection Sales by Company (2021-2026) & (K Units) Table 32. Global Carboplatin Injection Sales Share by Company (2021-2026) Table 33. Global Carboplatin Injection Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Carboplatin Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Carboplatin Injection Major Company Production Sites and Headquarters Table 36. Global Carboplatin Injection Company, Product Type & Application Table 37. Global Carboplatin Injection Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Carboplatin Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Carboplatin Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Carboplatin Injection Sales by Region (2021-2026) & (K Units) Table 42. Global Carboplatin Injection Sales Market Share in Volume by Region (2021-2026) Table 43. Global Carboplatin Injection Sales by Region (2021-2026) & (US$ Million) Table 44. Global Carboplatin Injection Sales Market Share in Value by Region (2021-2026) Table 45. Global Carboplatin Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Carboplatin Injection Sales by Region (2027-2032) & (K Units) Table 47. Global Carboplatin Injection Sales Market Share in Volume by Region (2027-2032) Table 48. Global Carboplatin Injection Sales by Region (2027-2032) & (US$ Million) Table 49. Global Carboplatin Injection Sales Market Share in Value by Region (2027-2032) Table 50. Global Carboplatin Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Carboplatin Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Carboplatin Injection Sales by Application (2021-2026) & (K Units) Table 53. Global Carboplatin Injection Sales Market Share in Volume by Application (2021-2026) Table 54. Global Carboplatin Injection Sales by Application (2021-2026) & (US$ Million) Table 55. Global Carboplatin Injection Sales Market Share in Value by Application (2021-2026) Table 56. Global Carboplatin Injection Price by Application (2021-2026) & (US$/Unit) Table 57. Global Carboplatin Injection Sales by Application (2027-2032) & (K Units) Table 58. Global Carboplatin Injection Sales Market Share in Volume by Application (2027-2032) Table 59. Global Carboplatin Injection Sales by Application (2027-2032) & (US$ Million) Table 60. Global Carboplatin Injection Sales Market Share in Value by Application (2027-2032) Table 61. Global Carboplatin Injection Price by Application (2027-2032) & (US$/Unit) Table 62. North America Carboplatin Injection Sales by Application (2021-2026) & (K Units) Table 63. North America Carboplatin Injection Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Carboplatin Injection Sales by Application (2021-2026) & (K Units) Table 65. Europe Carboplatin Injection Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Carboplatin Injection Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Carboplatin Injection Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Carboplatin Injection Sales by Application (2021-2026) & (K Units) Table 69. Latin America Carboplatin Injection Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Carboplatin Injection Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Carboplatin Injection Sales by Application (2021-2026) & (US$ Million) Table 72. Hisun Company Information Table 73. Hisun Business Overview Table 74. Hisun Carboplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Hisun Carboplatin Injection Product Portfolio Table 76. Hisun Recent Development Table 77. Yunnan Phytopharmaceutical Company Information Table 78. Yunnan Phytopharmaceutical Business Overview Table 79. Yunnan Phytopharmaceutical Carboplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Yunnan Phytopharmaceutical Carboplatin Injection Product Portfolio Table 81. Yunnan Phytopharmaceutical Recent Development Table 82. Yangzijiang Group Company Information Table 83. Yangzijiang Group Business Overview Table 84. Yangzijiang Group Carboplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Yangzijiang Group Carboplatin Injection Product Portfolio Table 86. Yangzijiang Group Recent Development Table 87. Teva Company Information Table 88. Teva Business Overview Table 89. Teva Carboplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Teva Carboplatin Injection Product Portfolio Table 91. Teva Recent Development Table 92. Shanghai Acebright Pharmaceuticals Company Information Table 93. Shanghai Acebright Pharmaceuticals Business Overview Table 94. Shanghai Acebright Pharmaceuticals Carboplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Shanghai Acebright Pharmaceuticals Carboplatin Injection Product Portfolio Table 96. Shanghai Acebright Pharmaceuticals Recent Development Table 97. Shandong Ruiying Company Information Table 98. Shandong Ruiying Business Overview Table 99. Shandong Ruiying Carboplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Shandong Ruiying Carboplatin Injection Product Portfolio Table 101. Shandong Ruiying Recent Development Table 102. Qilu Pharmaceutical Company Information Table 103. Qilu Pharmaceutical Business Overview Table 104. Qilu Pharmaceutical Carboplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Qilu Pharmaceutical Carboplatin Injection Product Portfolio Table 106. Qilu Pharmaceutical Recent Development Table 107. Mylan Company Information Table 108. Mylan Business Overview Table 109. Mylan Carboplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Mylan Carboplatin Injection Product Portfolio Table 111. Mylan Recent Development Table 112. Jiangsu Lianhuan Pharmaceutical Company Information Table 113. Jiangsu Lianhuan Pharmaceutical Business Overview Table 114. Jiangsu Lianhuan Pharmaceutical Carboplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Jiangsu Lianhuan Pharmaceutical Carboplatin Injection Product Portfolio Table 116. Jiangsu Lianhuan Pharmaceutical Recent Development Table 117. Fresenius Kabi Company Information Table 118. Fresenius Kabi Business Overview Table 119. Fresenius Kabi Carboplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Fresenius Kabi Carboplatin Injection Product Portfolio Table 121. Fresenius Kabi Recent Development Table 122. Cisen Pharmaceutical Company Information Table 123. Cisen Pharmaceutical Business Overview Table 124. Cisen Pharmaceutical Carboplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Cisen Pharmaceutical Carboplatin Injection Product Portfolio Table 126. Cisen Pharmaceutical Recent Development Table 127. Taj Pharmaceuticals Company Information Table 128. Taj Pharmaceuticals Business Overview Table 129. Taj Pharmaceuticals Carboplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Taj Pharmaceuticals Carboplatin Injection Product Portfolio Table 131. Taj Pharmaceuticals Recent Development Table 132. Hospira(Pfizer) Company Information Table 133. Hospira(Pfizer) Business Overview Table 134. Hospira(Pfizer) Carboplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Hospira(Pfizer) Carboplatin Injection Product Portfolio Table 136. Hospira(Pfizer) Recent Development Table 137. Bristol-Myers Squibb SA Company Information Table 138. Bristol-Myers Squibb SA Business Overview Table 139. Bristol-Myers Squibb SA Carboplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Bristol-Myers Squibb SA Carboplatin Injection Product Portfolio Table 141. Bristol-Myers Squibb SA Recent Development Table 142. North America Carboplatin Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. North America Carboplatin Injection Sales by Country (2021-2026) & (K Units) Table 144. North America Carboplatin Injection Sales Market Share by Country (2021-2026) Table 145. North America Carboplatin Injection Sales Forecast by Country (2027-2032) & (K Units) Table 146. North America Carboplatin Injection Sales Market Share Forecast by Country (2027-2032) Table 147. North America Carboplatin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. North America Carboplatin Injection Market Size by Country (2021-2026) & (US$ Million) Table 149. North America Carboplatin Injection Market Share by Country (2021-2026) Table 150. North America Carboplatin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. North America Carboplatin Injection Market Share Forecast by Country (2027-2032) Table 152. Europe Carboplatin Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 153. Europe Carboplatin Injection Sales by Country (2021-2026) & (K Units) Table 154. Europe Carboplatin Injection Sales Market Share by Country (2021-2026) Table 155. Europe Carboplatin Injection Sales Forecast by Country (2027-2032) & (K Units) Table 156. Europe Carboplatin Injection Sales Market Share Forecast by Country (2027-2032) Table 157. Europe Carboplatin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Europe Carboplatin Injection Market Size by Country (2021-2026) & (US$ Million) Table 159. Europe Carboplatin Injection Market Share by Country (2021-2026) Table 160. Europe Carboplatin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Europe Carboplatin Injection Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Carboplatin Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Carboplatin Injection Sales by Country (2021-2026) & (K Units) Table 164. Asia-Pacific Carboplatin Injection Sales Market Share by Country (2021-2026) Table 165. Asia-Pacific Carboplatin Injection Sales Forecast by Country (2027-2032) & (K Units) Table 166. Asia-Pacific Carboplatin Injection Sales Market Share Forecast by Country (2027-2032) Table 167. Asia-Pacific Carboplatin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Asia-Pacific Carboplatin Injection Market Size by Country (2021-2026) & (US$ Million) Table 169. Asia-Pacific Carboplatin Injection Market Share by Country (2021-2026) Table 170. Asia-Pacific Carboplatin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Asia-Pacific Carboplatin Injection Market Share Forecast by Country (2027-2032) Table 172. Latin America Carboplatin Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 173. Latin America Carboplatin Injection Sales by Country (2021-2026) & (K Units) Table 174. Latin America Carboplatin Injection Sales Market Share by Country (2021-2026) Table 175. Latin America Carboplatin Injection Sales Forecast by Country (2027-2032) & (K Units) Table 176. Latin America Carboplatin Injection Sales Market Share Forecast by Country (2027-2032) Table 177. Latin America Carboplatin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Latin America Carboplatin Injection Market Size by Country (2021-2026) & (US$ Million) Table 179. Latin America Carboplatin Injection Market Share by Country (2021-2026) Table 180. Latin America Carboplatin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Latin America Carboplatin Injection Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Carboplatin Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Carboplatin Injection Sales by Country (2021-2026) & (K Units) Table 184. Middle East and Africa Carboplatin Injection Sales Market Share by Country (2021-2026) Table 185. Middle East and Africa Carboplatin Injection Sales Forecast by Country (2027-2032) & (K Units) Table 186. Middle East and Africa Carboplatin Injection Sales Market Share Forecast by Country (2027-2032) Table 187. Middle East and Africa Carboplatin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 188. Middle East and Africa Carboplatin Injection Market Size by Country (2021-2026) & (US$ Million) Table 189. Middle East and Africa Carboplatin Injection Market Share by Country (2021-2026) Table 190. Middle East and Africa Carboplatin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 191. Middle East and Africa Carboplatin Injection Market Share Forecast by Country (2027-2032) Table 192. Key Raw Materials Table 193. Raw Materials Key Suppliers Table 194. Carboplatin Injection Distributors List Table 195. Carboplatin Injection Customers List Table 196. Research Programs/Design for This Report Table 197. Authors List of This Report Table 198. Secondary Sources Table 199. Primary Sources List of Figures Figure 1. Carboplatin Injection Image Figure 2. Global Carboplatin Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Carboplatin Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Carboplatin Injection Sales (2021-2032) & (K Units) Figure 5. 10ml:50mg Image Figure 6. Global 10ml:50mg Sales YoY Growth (2021-2032) & (K Units) Figure 7. 10ml:100mg Image Figure 8. Global 10ml:100mg Sales YoY Growth (2021-2032) & (K Units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Carboplatin Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Carboplatin Injection Market Share by Type 2025 VS 2032 Figure 13. North America Carboplatin Injection Sales Market Share in Volume by Type in 2025 Figure 14. North America Carboplatin Injection Sales Market Share in Value by Type in 2025 Figure 15. Europe Carboplatin Injection Sales Market Share in Volume by Type in 2025 Figure 16. Europe Carboplatin Injection Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Carboplatin Injection Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Carboplatin Injection Sales Market Share in Value by Type in 2025 Figure 19. Latin America Carboplatin Injection Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Carboplatin Injection Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Carboplatin Injection Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Carboplatin Injection Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Carboplatin Injection Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. SCLC Image Figure 26. Global SCLC Sales YoY Growth (2021-2032) & (K Units) Figure 27. Breast Cancer Image Figure 28. Global Breast Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 29. Ovarian Cancer Image Figure 30. Global Ovarian Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 31. Other Image Figure 32. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Carboplatin Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Carboplatin Injection Market Share by Application 2025 VS 2032 Figure 35. North America Carboplatin Injection Sales Market Share in Volume by Application in 2025 Figure 36. North America Carboplatin Injection Sales Market Share in Value by Application in 2025 Figure 37. Europe Carboplatin Injection Sales Market Share in Volume by Application in 2025 Figure 38. Europe Carboplatin Injection Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Carboplatin Injection Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Carboplatin Injection Sales Market Share in Value by Application in 2025 Figure 41. Latin America Carboplatin Injection Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Carboplatin Injection Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Carboplatin Injection Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Carboplatin Injection Sales Market Share in Value by Application in 2025 Figure 45. North America Carboplatin Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Carboplatin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Carboplatin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Carboplatin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Carboplatin Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Carboplatin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Carboplatin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Carboplatin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Carboplatin Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Carboplatin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Carboplatin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Carboplatin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Carboplatin Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Carboplatin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Carboplatin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Carboplatin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Carboplatin Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Carboplatin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Carboplatin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Carboplatin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Carboplatin Injection Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Carboplatin Injection Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 10ml:50mg
  • 10ml:100mg
  • Other
Applications
  • SCLC
  • Breast Cancer
  • Ovarian Cancer
  • Other
Companies covered
  • Hisun
  • Yunnan Phytopharmaceutical
  • Yangzijiang Group
  • Teva
  • Shanghai Acebright Pharmaceuticals
  • Shandong Ruiying
  • Qilu Pharmaceutical
  • Mylan
  • Jiangsu Lianhuan Pharmaceutical
  • Fresenius Kabi
  • Cisen Pharmaceutical
  • Taj Pharmaceuticals
  • Hospira(Pfizer)
  • Bristol-Myers Squibb SA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Carboplatin Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Carboplatin Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Carboplatin Injection Market by Type
  6. 1.3.1 10ml:50mg
  7. 1.3.2 10ml:100mg
  8. 1.3.3 Other
  9. 1.4 Global Carboplatin Injection Market Size by Type
  10. 1.4.1 Global Carboplatin Injection Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Carboplatin Injection Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Carboplatin Injection Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Carboplatin Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Carboplatin Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Carboplatin Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Carboplatin Injection Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Carboplatin Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Carboplatin Injection Industry Trends
  2. 2.2 Carboplatin Injection Industry Drivers
  3. 2.3 Carboplatin Injection Industry Opportunities and Challenges
  4. 2.4 Carboplatin Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Carboplatin Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Carboplatin Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Carboplatin Injection Price (2021-2026)
  4. 3.4 Global Carboplatin Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Carboplatin Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Carboplatin Injection Company, Product Type & Application
  7. 3.7 Global Carboplatin Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Carboplatin Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Carboplatin Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Carboplatin Injection Tier 1, Tier 2, and Tier 3
4 Carboplatin Injection Regional Status and Outlook
  1. 4.1 Global Carboplatin Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Carboplatin Injection Historic Market Size by Region
  3. 4.2.1 Global Carboplatin Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Carboplatin Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Carboplatin Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Carboplatin Injection Forecasted Market Size by Region
  7. 4.3.1 Global Carboplatin Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Carboplatin Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Carboplatin Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Carboplatin Injection by Application
  1. 5.1 Carboplatin Injection Market by Application
  2. 5.1.1 SCLC
  3. 5.1.2 Breast Cancer
  4. 5.1.3 Ovarian Cancer
  5. 5.1.4 Other
  6. 5.2 Global Carboplatin Injection Market Size by Application
  7. 5.2.1 Global Carboplatin Injection Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Carboplatin Injection Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Carboplatin Injection Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Carboplatin Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Carboplatin Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Carboplatin Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Carboplatin Injection Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Carboplatin Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Hisun
  2. 6.1.1 Hisun Company Information
  3. 6.1.2 Hisun Business Overview
  4. 6.1.3 Hisun Carboplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Hisun Carboplatin Injection Product Portfolio
  6. 6.1.5 Hisun Recent Developments
  7. 6.2 Yunnan Phytopharmaceutical
  8. 6.2.1 Yunnan Phytopharmaceutical Company Information
  9. 6.2.2 Yunnan Phytopharmaceutical Business Overview
  10. 6.2.3 Yunnan Phytopharmaceutical Carboplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Yunnan Phytopharmaceutical Carboplatin Injection Product Portfolio
  12. 6.2.5 Yunnan Phytopharmaceutical Recent Developments
  13. 6.3 Yangzijiang Group
  14. 6.3.1 Yangzijiang Group Company Information
  15. 6.3.2 Yangzijiang Group Business Overview
  16. 6.3.3 Yangzijiang Group Carboplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Yangzijiang Group Carboplatin Injection Product Portfolio
  18. 6.3.5 Yangzijiang Group Recent Developments
  19. 6.4 Teva
  20. 6.4.1 Teva Company Information
  21. 6.4.2 Teva Business Overview
  22. 6.4.3 Teva Carboplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Teva Carboplatin Injection Product Portfolio
  24. 6.4.5 Teva Recent Developments
  25. 6.5 Shanghai Acebright Pharmaceuticals
  26. 6.5.1 Shanghai Acebright Pharmaceuticals Company Information
  27. 6.5.2 Shanghai Acebright Pharmaceuticals Business Overview
  28. 6.5.3 Shanghai Acebright Pharmaceuticals Carboplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Shanghai Acebright Pharmaceuticals Carboplatin Injection Product Portfolio
  30. 6.5.5 Shanghai Acebright Pharmaceuticals Recent Developments
  31. 6.6 Shandong Ruiying
  32. 6.6.1 Shandong Ruiying Company Information
  33. 6.6.2 Shandong Ruiying Business Overview
  34. 6.6.3 Shandong Ruiying Carboplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Shandong Ruiying Carboplatin Injection Product Portfolio
  36. 6.6.5 Shandong Ruiying Recent Developments
  37. 6.7 Qilu Pharmaceutical
  38. 6.7.1 Qilu Pharmaceutical Company Information
  39. 6.7.2 Qilu Pharmaceutical Business Overview
  40. 6.7.3 Qilu Pharmaceutical Carboplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Qilu Pharmaceutical Carboplatin Injection Product Portfolio
  42. 6.7.5 Qilu Pharmaceutical Recent Developments
  43. 6.8 Mylan
  44. 6.8.1 Mylan Company Information
  45. 6.8.2 Mylan Business Overview
  46. 6.8.3 Mylan Carboplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Mylan Carboplatin Injection Product Portfolio
  48. 6.8.5 Mylan Recent Developments
  49. 6.9 Jiangsu Lianhuan Pharmaceutical
  50. 6.9.1 Jiangsu Lianhuan Pharmaceutical Company Information
  51. 6.9.2 Jiangsu Lianhuan Pharmaceutical Business Overview
  52. 6.9.3 Jiangsu Lianhuan Pharmaceutical Carboplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Jiangsu Lianhuan Pharmaceutical Carboplatin Injection Product Portfolio
  54. 6.9.5 Jiangsu Lianhuan Pharmaceutical Recent Developments
  55. 6.10 Fresenius Kabi
  56. 6.10.1 Fresenius Kabi Company Information
  57. 6.10.2 Fresenius Kabi Business Overview
  58. 6.10.3 Fresenius Kabi Carboplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Fresenius Kabi Carboplatin Injection Product Portfolio
  60. 6.10.5 Fresenius Kabi Recent Developments
  61. 6.11 Cisen Pharmaceutical
  62. 6.11.1 Cisen Pharmaceutical Company Information
  63. 6.11.2 Cisen Pharmaceutical Business Overview
  64. 6.11.3 Cisen Pharmaceutical Carboplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Cisen Pharmaceutical Carboplatin Injection Product Portfolio
  66. 6.11.5 Cisen Pharmaceutical Recent Developments
  67. 6.12 Taj Pharmaceuticals
  68. 6.12.1 Taj Pharmaceuticals Company Information
  69. 6.12.2 Taj Pharmaceuticals Business Overview
  70. 6.12.3 Taj Pharmaceuticals Carboplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Taj Pharmaceuticals Carboplatin Injection Product Portfolio
  72. 6.12.5 Taj Pharmaceuticals Recent Developments
  73. 6.13 Hospira(Pfizer)
  74. 6.13.1 Hospira(Pfizer) Company Information
  75. 6.13.2 Hospira(Pfizer) Business Overview
  76. 6.13.3 Hospira(Pfizer) Carboplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Hospira(Pfizer) Carboplatin Injection Product Portfolio
  78. 6.13.5 Hospira(Pfizer) Recent Developments
  79. 6.14 Bristol-Myers Squibb SA
  80. 6.14.1 Bristol-Myers Squibb SA Company Information
  81. 6.14.2 Bristol-Myers Squibb SA Business Overview
  82. 6.14.3 Bristol-Myers Squibb SA Carboplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Bristol-Myers Squibb SA Carboplatin Injection Product Portfolio
  84. 6.14.5 Bristol-Myers Squibb SA Recent Developments
7 North America by Country
  1. 7.1 North America Carboplatin Injection Sales by Country
  2. 7.1.1 North America Carboplatin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Carboplatin Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Carboplatin Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Carboplatin Injection Market Size by Country
  6. 7.2.1 North America Carboplatin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Carboplatin Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Carboplatin Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Carboplatin Injection Sales by Country
  2. 8.1.1 Europe Carboplatin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Carboplatin Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Carboplatin Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Carboplatin Injection Market Size by Country
  6. 8.2.1 Europe Carboplatin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Carboplatin Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Carboplatin Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Carboplatin Injection Sales by Country
  2. 9.1.1 Asia-Pacific Carboplatin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Carboplatin Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Carboplatin Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Carboplatin Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Carboplatin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Carboplatin Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Carboplatin Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Carboplatin Injection Sales by Country
  2. 10.1.1 South America Carboplatin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Carboplatin Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Carboplatin Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Carboplatin Injection Market Size by Country
  6. 10.2.1 South America Carboplatin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Carboplatin Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Carboplatin Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Carboplatin Injection Sales by Country
  2. 11.1.1 Middle East and Africa Carboplatin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Carboplatin Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Carboplatin Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Carboplatin Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Carboplatin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Carboplatin Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Carboplatin Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Carboplatin Injection Value Chain Analysis
  2. 12.1.1 Carboplatin Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Carboplatin Injection Production Mode & Process
  7. 12.2 Carboplatin Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Carboplatin Injection Distributors
  10. 12.2.3 Carboplatin Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst